Systemic Lupus Erythematosus
📧 Sign up to get email alerts when something new happens for Systemic Lupus Erythematosus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-04-02Clinical Trial Update: BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases [Phase 2]
Phase 2 clinical trial update on BCMA-CD19 CAR-T therapy for refractory autoimmune diseases, currently recruiting. The study targets several…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children [Phase 3]
This document updates on a Phase 3 clinical trial evaluating CAR-T cell therapy for refractory or recurrent lupus nephritis in children, whi…
-
CLINICAL_TRIALS research · 2025-03-31Clinical Trial Update: Systemic Lupus Erythematosus and Chlordecone Impregnation in Martinique
A clinical trial in Martinique is evaluating chlordecone impregnation for systemic lupus erythematosus with renal involvement; recruitment i…
-
CLINICAL_TRIALS research · 2025-03-30Clinical Trial Update: Equecabtagene Autoleucel Injection (Eque-cel) for Relapsed/Refractory Systemic Lupus Erythematosus (SLE) [NA]
Clinical trial update indicates ongoing recruitment for Equecabtagene autoleucel (Eque-cel), a CAR-T therapy, for relapsed/refractory system…
-
CLINICAL_TRIALS trial_result · 2025-03-28Clinical Trial Update: Improving the Assessment of SLE Disease Activity
A completed clinical trial update describing efforts to improve the assessment of disease activity in systemic lupus erythematosus (SLE).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-27Clinical Trial Update: Myofascial Techniques and Proprioceptive Neuromuscular Facilitation in Patients With Systemic Lupus Erythematosus. [NA]
This clinical trial update reports on a completed study evaluating myofascial techniques and proprioceptive neuromuscular facilitation in pa…
-
CLINICAL_TRIALS research · 2025-03-27Clinical Trial Update: Adjunctive Yu-Tone Music Therapy for Systemic Lupus Erythematosus: a Prospective Cohort Study
This update describes an ongoing prospective cohort study evaluating Yu-Tone music therapy as an adjunct to standard care for systemic lupus…
-
CLINICAL_TRIALS research · 2025-03-26Clinical Trial Update: CD19/BCMA CAR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus [Phase 1]
Phase 1 clinical trial evaluating CD19/BCMA CAR-T cell therapy for refractory or moderate-to-severe systemic lupus erythematosus. The study …
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: Clinical Study Evaluating the Safety and Efficacy of IC19 CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus [EARLY_Phase 1]
An early-phase trial evaluating the safety and efficacy of IC19 CAR-T Cell Therapy for refractory systemic lupus erythematosus is not yet re…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases [Phase 1, Phase 2]
Ongoing Phase 1/Phase 2 clinical trial updates describe infusion of mesenchymal stem cells in multiple autoimmune diseases and indicate the …
-
CLINICAL_TRIALS trial_result · 2025-03-21Clinical Trial Update: Observational Multicenter Case-control Study to Assess Nailfold Capillary Abnormalities in Systemic Lupus Erythematosus
A completed multicenter observational case-control study investigating nailfold capillary abnormalities in patients with Systemic Lupus Eryt…
-
CLINICAL_TRIALS withdrawal · 2025-03-13Clinical Trial Update: A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or Lupus [Phase 1]
A Phase 1 clinical trial evaluating the safety of gusacitinib in patients with systemic lupus erythematosus has been withdrawn.
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments
A Strasbourg-based study is evaluating whether physician consideration of electronic patient-reported outcomes from patients with gout, rheu…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: Assessment of Blood Indices in Systemic Lupus Erythematosus
This clinical trial update reports on assessing blood indices in patients with systemic lupus erythematosus; the study is currently not yet …
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus
A completed study developing a decision aid to help lupus patients understand hydroxychloroquine and dispel common misbeliefs about its use.
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE) [Phase 2]
Clinical trial update for a Phase 2 study of TQB3702 tablets in systemic lupus erythematosus; the trial is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Clinical Study of ZM001 Injection in the Treatment of Refractory Systemic Lupus Erythematosus [Phase 1]
Phase 1 clinical trial update for ZM001 injection in refractory systemic lupus erythematosus; currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: The Prevalence Evaluation of Systemic Lupus Erythematosus in Russian Patients With Reproductive Issues (PRISMA)
This entry notes the completion of AstraZeneca's PRISMA trial evaluating the prevalence of systemic lupus erythematosus in Russian patients …
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Fibroblast Growth Factor 21 in Systemic Lupus Erythematosus
A ClinicalTrials.gov listing describes a study evaluating Fibroblast Growth Factor 21 in systemic lupus erythematosus. The trial is currentl…
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: A Study of SCTB35 in Patients with Systemic Lupus Erythematosus [Phase 1, Phase 2]
Clinical trial update for SCTB35 in patients with systemic lupus erythematosus, currently recruiting in Phase 1/Phase 2.
-
CLINICAL_TRIALS trial_result · 2025-02-20Clinical Trial Update: A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers [Phase 1]
Phase I study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of subcutaneously administered CUG252 in healthy volunt…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: Predictors of Bone Mineral Density in Lupus Nephritis Activity
Assiut University is conducting a clinical trial to identify predictors of bone mineral density in patients with lupus nephritis activity; t…
-
CLINICAL_TRIALS research · 2025-02-20Clinical Trial Update: A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus [Phase 1]
A Phase 1 clinical trial update for a treatment in patients with mild-to-moderate systemic lupus erythematosus, currently active and not rec…
-
FDA approval · 2025-02-13FDA Approved: PREDNISOLONE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental Abbreviated New Drug Application for a generic prednisolone product from PAI Holdings/PAI Pharma, signaling regu…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Telehealth CBT for Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus [NA]
A completed clinical trial evaluated telehealth cognitive behavioral therapy for adolescents and young adults with childhood-onset systemic …